Skip to main content
iwCLL 2025 Main banner
Final Program


Save The Date

    Tadeusz Robak, MD, PhD

    Professor of Hematology; Head, Department of General Hematology & Internal Medicine
    Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital
    Łódź, Lodzkie, Poland

    Tadeusz Robak, MD, PhD
    Professor, Department of Hematology
    Medical University of Lodz, Lodz, Poland

    Biography

    Tadeusz Robak, MD, PhD, is Professor of Hematology at the Medical University oof Lodz and the head of the General Hematology Hematology and Internal Medicine at Copernicus Memorial Hospital in Lodz, Poland. He is former president of the Polish Society of Hematology and Transfusion Medicine and a member of the European School of Haematology Scientific Committee. He is the (co-)author of more than 750 scientific papers published in peer-reviewed journals. His research activities are focused mainly on chronic lymphocytic leukemia (CLL), hairy cell leukemia (HCL) and lymphoma, particularly on new protocols with purine analogues and targeted drugs. He participated in the pivotal clinical studies that influenced therapeutic standards in these diseases. Professor Robak was principal investigator in Polish multi-centre phase-3 trials, the results of which contributed to the use of cladribine in CLL and HCL. He was principal investigator in REACH and COMPLEMENT2 trials, key for the introduction of immunochemotherapy in relapsed/refractory CLL and in LYM 3002 study on the use of bortezomib (VR-CAP) in the first line of mantle cell lymphoma therapy. He presented the results of his clinical research at the ASH, EHA and EBMT meetings. He is one of the authors of the IWCLL and ESMO guidelines for CLL and ESMO guidelines for HCL. Prof. Robak is a member of the ASH, EHA and IWCLL. In 2021 Prof. Robak organized virtual XIX iwCLL Meeting and in 2025 XXI iwCLL Meeting in Kraków, Poland

    Presentation(s):